10:16 AM EST - Knight Therapeutics Inc. : Today reported financial results for its fourth quarter ended December 31, 2024. Revenues were $371,304, an increase of $43,105 or 13% over the prior year. Net income was $4,332, compared to a net loss $16,835 in prior year. Knight Therapeutics Inc.
shares T.GUD are trading up $0.17 at $6.42.
